Arun Villivalam, MD
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Villivalam’s office at (408) 502-6040 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A73520 · Current
Licensed to practise in California · since 2000 · expires 2028-09-30 · Jefferson Medical College of Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$172,936
Medicare paid this office $172,936 for 305 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 250 | $68,628 | $116 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 240 | $37,762 | $157 |
| Advance care planning, first 30 minutes | 244 | $22,538 | $92 |
| New patient visit (45+ min) | 103 | $11,881 | $115 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 274 | $10,661 | $14 |
See all 13 services
| Return visit (30+ min) | 250 | $68,628 | $116 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 240 | $37,762 | $157 |
| Advance care planning, first 30 minutes | 244 | $22,538 | $92 |
| New patient visit (45+ min) | 103 | $11,881 | $115 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 274 | $10,661 | $14 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 37 | $6,924 | $51 |
| Transitional care management services for problem of at least moderate complexity | 20 | $5,071 | $203 |
| Transitional care management services for problem of high complexity | 12 | $3,249 | $271 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 49 | $1,242 | $23 |
| Short return visit (20+ min) | 13 | $1,057 | $81 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 39 | $855 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $281 | $12 |
| Administration and interpretation of patient-focused health risk assessment | 64 | $209 | $3 |
Who their Medicare patients are
305 Original Medicare patients in 2024. Average age 76 · Women 44% · Also on Medicaid 7% · Health risk score 1.20. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 41% · Diabetes 33% · Depression 26% · Chronic kidney disease 24% · Cancer 22% · Atrial fibrillation 20% · Heart failure 17% · Stroke 13% · COPD 11% · Dementia 10%.
The office billed $489,115, Medicare allowed $213,665 and paid $172,936; for 2,324 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 305 | 2,324 | 76 | 1.20 | $489,115 | $172,936 |
| 2023 | 253 | 1,040 | 76 | 1.16 | $301,625 | $110,370 |
| 2022 | 252 | 1,208 | 76 | 1.22 | $308,900 | $121,099 |
| 2021 | 195 | 1,299 | 77 | 1.12 | $270,055 | $135,161 |
| 2020 | 183 | 1,141 | 76 | 1.51 | $212,790 | $97,412 |
| 2019 | 358 | 1,925 | 78 | 1.68 | $374,200 | $165,203 |
| 2018 | 372 | 2,061 | 79 | 1.78 | $407,815 | $182,637 |
| 2017 | 131 | 531 | 76 | 1.27 | $122,875 | $46,082 |
| 2016 | 73 | 241 | 74 | 1.23 | $56,520 | $22,424 |
| 2015 | 49 | 94 | 75 | 1.02 | $21,457 | $6,198 |
| 2014 | 60 | 110 | 74 | 1.24 | $20,855 | $5,591 |
| 2013 | 110 | 350 | 75 | 0.78 | $29,854 | $13,810 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 176 | $48,322 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 163 | $25,412 | $156 |
| Advance care planning, first 30 minutes | 179 | $16,768 | $94 |
| New patient visit (45+ min) | 60 | $7,913 | $132 |
| Short return visit (20+ min) | 19 | $1,803 | $82 |
| Insertion of needle into vein for collection of blood sample | 25 | $470 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $170 | $11 |
2022: 9 services
| Return visit (30+ min) | 181 | $53,483 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 154 | $24,444 | $159 |
| Advance care planning, first 30 minutes | 167 | $15,786 | $95 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 36 | $7,544 | $50 |
| Short return visit (20+ min) | 58 | $5,781 | $77 |
| New patient visit (45+ min) | 36 | $4,938 | $137 |
| New patient visit (30+ min) | 28 | $1,819 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $237 | $14 |
| Insertion of needle into vein for collection of blood sample | 30 | $163 | $3 |
2021: 8 services
| Return visit (30+ min) | 172 | $63,740 | $113 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $20,956 | $161 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 48 | $19,142 | $67 |
| Advance care planning, first 30 minutes | 141 | $13,901 | $99 |
| New patient visit (30+ min) | 43 | $3,915 | $91 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,450 | $203 |
| Short return visit (20+ min) | 28 | $3,069 | $77 |
| New patient visit (45+ min) | 11 | $1,771 | $161 |
2020: 9 services
| Return visit (30+ min) | 152 | $59,669 | $97 |
| Short return visit (20+ min) | 56 | $7,262 | $69 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 35 | $5,240 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,207 | $139 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 73 | $2,995 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $2,724 | $63 |
| New patient visit (30+ min) | 31 | $2,423 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,736 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,466 | $73 |
2019: 13 services
| Return visit (30+ min) | 152 | $57,483 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 152 | $32,567 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 167 | $21,847 | $119 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 77 | $10,709 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $8,831 | $93 |
| Hospital discharge day management, 30 minutes or less | 106 | $7,720 | $67 |
| New patient visit (30+ min) | 68 | $5,758 | $85 |
| Hospital discharge day management, more than 30 minutes | 48 | $4,886 | $98 |
| Short return visit (20+ min) | 52 | $4,873 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,979 | $181 |
| Influenza vaccine split virus, preservative free | 37 | $2,086 | $55 |
| Administration of influenza virus vaccine | 37 | $779 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $198 | $12 |
2018: 13 services
| Return visit (30+ min) | 109 | $45,927 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 180 | $37,915 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $21,158 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 110 | $20,729 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 126 | $16,954 | $122 |
| Hospital discharge day management, 30 minutes or less | 135 | $9,695 | $66 |
| Hospital discharge day management, more than 30 minutes | 65 | $6,616 | $99 |
| Short return visit (20+ min) | 56 | $6,574 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,790 | $140 |
| New patient visit (30+ min) | 45 | $3,735 | $83 |
| Administration of influenza virus vaccine | 16 | $412 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $346 | $16 |
| Influenza vaccine, quadrivalent derived from cell cultures | 15 | $335 | $22 |
2017: 10 services
| Return visit (30+ min) | 92 | $26,226 | $87 |
| Short return visit (20+ min) | 38 | $3,488 | $68 |
| New patient visit (30+ min) | 35 | $3,302 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,771 | $139 |
| New patient visit (45+ min) | 23 | $2,550 | $111 |
| Pneumococcal vaccine, 13-valent | 11 | $2,077 | $189 |
| Influenza vaccine split virus, preservative free | 13 | $625 | $48 |
| Administration of influenza virus vaccine | 13 | $420 | $32 |
| Administration of pneumococcal vaccine | 12 | $387 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $247 | $16 |
2016: 4 services
| Return visit (30+ min) | 52 | $14,433 | $99 |
| New patient visit (45+ min) | 39 | $5,669 | $145 |
| Administration of influenza virus vaccine | 19 | $570 | $30 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 19 | $283 | $15 |
2015: 2 services
| Return visit (30+ min) | 23 | $2,841 | $81 |
| Short return visit (20+ min) | 28 | $1,992 | $57 |
2014: 1 service
| Short return visit (20+ min) | 49 | $4,029 | $54 |
2013: 8 services
| Return visit (30+ min) | 74 | $7,721 | $75 |
| Short return visit (20+ min) | 26 | $2,129 | $61 |
| Blood test, thyroid stimulating hormone (tsh) | 12 | $274 | $23 |
| Blood test, comprehensive group of blood chemicals | 21 | $263 | $13 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 18 | $189 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $165 | $14 |
| Insertion of needle into vein for collection of blood sample | 34 | $109 | $3 |
| Automated urinalysis test | 12 | $43 | $3 |
Medicaid work
$55,311 in 2024
Medicaid paid $55,311 for 831 billed services this clinician did in 2024, up to 132 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 380 | $46,651 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 211 | $3,772 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 78 | $3,510 |
| Self-measured blood pressure using a device validated for clinical accuracy; separate self-measurements of two readings one minute apart, twice daily over a 30-day period (minimum of 12 readings), collection of data reported by the patient and/or caregiver to the physician or other qualified health care professional, with report of average systolic and diastolic pressures and subsequent communication of a treatment plan to the patient | 162 | $1,378 |
| 2024 | 831 | 4 | 132 | $55,311 |
| 2023 | 724 | 10 | 151 | $32,844 |
| 2022 | 33 | 1 | 33 | $752 |
See the largest Medicaid services in earlier years
2023
| OFF/OP EST MAY X REQ PHY/QHP | 270 | $26,322 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 116 | $2,200 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 47 | $2,183 |
| UNLISTED HOME VISIT SVC/PX | 44 | $880 |
| Other evaluation and management service | 78 | $772 |
| Self-measured blood pressure using a device validated for clinical accuracy; separate self-measurements of two readings one minute apart, twice daily over a 30-day period (minimum of 12 readings), collection of data reported by the patient and/or caregiver to the physician or other qualified health care professional, with report of average systolic and diastolic pressures and subsequent communication of a treatment plan to the patient | 50 | $487 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 37 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 29 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 28 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 25 | $0 |
2022
| OFF/OP EST MAY X REQ PHY/QHP | 33 | $752 |
Drugs they prescribed that Part D paid
$159,923
Pharmacies billed $159,923 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,718 generic and fewer than 11 brand-name prescriptions · $159,923 in drug cost · 38 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 35 | $33,527 | $958 |
| Januvia | 12 | $14,472 | $1,206 |
| Trulicity | 12 | $11,537 | $961 |
| Advair Hfa | 24 | $10,069 | $420 |
| Vytorin | 11 | $4,104 | $373 |
See all 54 drugs
| Eliquis | 35 | $33,527 | $958 |
| Januvia | 12 | $14,472 | $1,206 |
| Trulicity | 12 | $11,537 | $961 |
| Advair Hfa | 24 | $10,069 | $420 |
| Vytorin | 11 | $4,104 | $373 |
| Rosuvastatin | 351 | $3,766 | $11 |
| Paxlovid | 23 | $2,859 | $124 |
| Humalog Kwikpen U-100 | 15 | $2,675 | $178 |
| Atorvastatin | 319 | $2,334 | $7 |
| Levothyroxine | 206 | $2,315 | $11 |
| Wixela Inhub | 20 | $1,564 | $78 |
| Metformin Hcl Er | 152 | $1,168 | $8 |
| Metoprolol | 67 | $1,105 | $16 |
| Tamsulosin | 66 | $1,049 | $16 |
| Bupropion Xl | 28 | $764 | $27 |
| Losartan | 80 | $742 | $9 |
| Gabapentin | 49 | $691 | $14 |
| Azelastine | 26 | $663 | $25 |
| Amlodipine Besylate | 100 | $608 | $6 |
| Ezetimibe | 29 | $579 | $20 |
| Trazodone | 74 | $566 | $8 |
| Losartan-Hydrochlorothiazide | 22 | $552 | $25 |
| Olmesartan-Hydrochlorothiazide | 13 | $543 | $42 |
| Montelukast | 30 | $524 | $17 |
| Lisinopril | 65 | $522 | $8 |
| Omeprazole | 37 | $502 | $14 |
| Hydralazine | 18 | $477 | $26 |
| Metformin | 59 | $405 | $7 |
| Valacyclovir | 19 | $372 | $20 |
| Pantoprazole | 42 | $327 | $8 |
| Finasteride | 28 | $317 | $11 |
| Bicalutamide | 13 | $274 | $21 |
| Sertraline | 49 | $270 | $6 |
| Mirtazapine | 19 | $263 | $14 |
| Duloxetine | 17 | $257 | $15 |
| Nitrofurantoin Mono-Macro | 15 | $251 | $17 |
| Simvastatin | 39 | $249 | $6 |
| Celecoxib | 16 | $244 | $15 |
| Pravastatin | 22 | $242 | $11 |
| Atenolol | 31 | $238 | $8 |
| Diclofenac | 15 | $221 | $15 |
| Escitalopram | 21 | $212 | $10 |
| Hydrochlorothiazide | 30 | $207 | $7 |
| Allopurinol | 31 | $199 | $6 |
| Lisinopril-Hydrochlorothiazide | 31 | $179 | $6 |
| Valsartan-Hydrochlorothiazide | 19 | $166 | $9 |
| Zolpidem | 14 | $127 | $9 |
| Prednisone | 29 | $124 | $4 |
| Sildenafil Citrate | 11 | $102 | $9 |
| Glimepiride | 13 | $92 | $7 |
| Cyclobenzaprine | 14 | $66 | $5 |
| Furosemide | 21 | $48 | $2 |
| Spironolactone | 13 | $46 | $4 |
| Fluoxetine | 15 | $35 | $2 |
Year by year
| 2024 | 3,002 | 331 | None | None | $159,923 |
| 2023 | 2,596 | 286 | None | 8% | $162,381 |
| 2022 | 2,424 | 244 | None | 12% | $173,768 |
| 2021 | 1,908 | 207 | None | None | $116,334 |
| 2020 | 2,313 | 194 | None | None | $144,114 |
| 2019 | 2,017 | 240 | 1% (14) | 19% | $154,488 |
| 2018 | 1,365 | 165 | 1% (15) | 18% | $103,815 |
| 2017 | 781 | 95 | 3% (24) | 19% | $62,029 |
| 2016 | 516 | 64 | 5% (27) | 22% | $43,680 |
| 2015 | 224 | 58 | 10% (23) | 16% | $6,026 |
| 2014 | 163 | 62 | None | 18% | $4,884 |
| 2013 | 64 | 31 | 0% (0) | 28% | $4,082 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Eliquis | 16 | $17,155 | $1,072 |
| Xarelto | 13 | $13,428 | $1,033 |
| Trulicity | 12 | $12,076 | $1,006 |
| Humalog Kwikpen U-100 | 13 | $7,409 | $570 |
| Repatha Sureclick | 11 | $6,545 | $595 |
| Flovent Hfa | 13 | $5,893 | $453 |
| Atorvastatin | 373 | $4,577 | $12 |
| Vytorin | 11 | $4,519 | $411 |
| Levothyroxine | 168 | $2,727 | $16 |
| Rosuvastatin | 117 | $2,238 | $19 |
| Ezetimibe | 29 | $1,922 | $66 |
| Bupropion Xl | 32 | $1,805 | $56 |
| Metformin Hcl Er | 161 | $1,378 | $9 |
| Trazodone | 82 | $1,237 | $15 |
| Amlodipine Besylate | 86 | $1,175 | $14 |
| Olmesartan-Hydrochlorothiazide | 23 | $1,158 | $50 |
| Losartan | 57 | $1,117 | $20 |
| Duloxetine | 13 | $1,088 | $84 |
| Metoprolol | 50 | $1,039 | $21 |
| Tamsulosin | 53 | $1,034 | $20 |
| Losartan-Hydrochlorothiazide | 49 | $967 | $20 |
| Pantoprazole | 48 | $872 | $18 |
| Omeprazole | 39 | $781 | $20 |
| Montelukast | 36 | $753 | $21 |
| Metformin | 55 | $719 | $13 |
| Gabapentin | 51 | $668 | $13 |
| Lisinopril | 39 | $608 | $16 |
| Valsartan | 20 | $525 | $26 |
| Albuterol Sulfate Hfa | 18 | $514 | $29 |
| Valacyclovir | 17 | $420 | $25 |
| Fenofibrate | 16 | $399 | $25 |
| Allopurinol | 33 | $373 | $11 |
| Sertraline | 22 | $354 | $16 |
| Lisinopril-Hydrochlorothiazide | 65 | $343 | $5 |
| Simvastatin | 39 | $313 | $8 |
| Glipizide Er | 22 | $247 | $11 |
| Atenolol | 24 | $244 | $10 |
| Escitalopram | 15 | $242 | $16 |
| Paxlovid (Eua) | 24 | $242 | $10 |
| Glipizide | 13 | $231 | $18 |
| Hydrochlorothiazide | 28 | $231 | $8 |
| Fluoxetine | 14 | $209 | $15 |
| Nitrofurantoin Mono-Macro | 14 | $207 | $15 |
| Finasteride | 11 | $194 | $18 |
| Zolpidem | 12 | $179 | $15 |
| Oxybutynin Chloride | 11 | $99 | $9 |
| Glimepiride | 11 | $92 | $8 |
| Furosemide | 15 | $88 | $6 |
| Benazepril | 14 | $84 | $6 |
| Prednisone | 13 | $49 | $4 |
2022: 50 drugs
| Eliquis | 45 | $40,457 | $899 |
| Xarelto | 18 | $13,351 | $742 |
| Flovent Hfa | 28 | $12,703 | $454 |
| Trulicity | 11 | $10,596 | $963 |
| Lantus Solostar | 12 | $6,472 | $539 |
| Atorvastatin | 380 | $4,570 | $12 |
| Vytorin | 12 | $4,530 | $378 |
| Levothyroxine | 144 | $2,863 | $20 |
| Ezetimibe | 28 | $2,106 | $75 |
| Bupropion Xl | 40 | $1,979 | $49 |
| Duloxetine | 16 | $1,348 | $84 |
| Synthroid | 14 | $1,148 | $82 |
| Tamsulosin | 42 | $1,118 | $27 |
| Rosuvastatin | 75 | $1,099 | $15 |
| Metformin Hcl Er | 150 | $1,063 | $7 |
| Montelukast | 43 | $976 | $23 |
| Valacyclovir | 27 | $964 | $36 |
| Ventolin Hfa | 15 | $921 | $61 |
| Trazodone | 68 | $895 | $13 |
| Metoprolol | 42 | $817 | $19 |
| Amlodipine Besylate | 73 | $793 | $11 |
| Gabapentin | 41 | $777 | $19 |
| Diclofenac | 25 | $660 | $26 |
| Losartan | 67 | $646 | $10 |
| Albuterol Sulfate Hfa | 12 | $534 | $44 |
| Lisinopril | 48 | $528 | $11 |
| Losartan-Hydrochlorothiazide | 23 | $509 | $22 |
| Pantoprazole | 18 | $474 | $26 |
| Metformin | 44 | $472 | $11 |
| Lisinopril-Hydrochlorothiazide | 70 | $464 | $7 |
| Allopurinol | 39 | $455 | $12 |
| Bupropion Hcl Sr | 19 | $416 | $22 |
| Sertraline | 22 | $355 | $16 |
| Fosinopril | 15 | $344 | $23 |
| Hydrochlorothiazide | 44 | $322 | $7 |
| Diltiazem 24hr Er (Cd) | 17 | $292 | $17 |
| Glimepiride | 14 | $292 | $21 |
| Glipizide Er | 13 | $229 | $18 |
| Glipizide | 18 | $217 | $12 |
| Simvastatin | 28 | $204 | $7 |
| Atenolol | 19 | $203 | $11 |
| Paxlovid (Eua) | 20 | $193 | $10 |
| Pioglitazone | 13 | $132 | $10 |
| Furosemide | 24 | $132 | $5 |
| Nortriptyline | 22 | $101 | $5 |
| Citalopram Hbr | 11 | $91 | $8 |
| Metoprolol | 15 | $84 | $6 |
| Prednisone | 18 | $54 | $3 |
| Sildenafil Citrate | 13 | $50 | $4 |
| Triamcinolone Acetonide | 12 | $49 | $4 |
2021: 37 drugs
| Trulicity | 11 | $11,597 | $1,054 |
| Xarelto | 15 | $7,891 | $526 |
| Jardiance | 12 | $6,459 | $538 |
| Atorvastatin | 354 | $4,691 | $13 |
| Flovent Hfa | 13 | $4,607 | $354 |
| Levothyroxine | 128 | $2,861 | $22 |
| Shingrix | 14 | $2,582 | $184 |
| Ezetimibe | 27 | $2,524 | $93 |
| Bupropion Xl | 37 | $1,620 | $44 |
| Montelukast | 54 | $993 | $18 |
| Gabapentin | 54 | $811 | $15 |
| Metformin Hcl Er | 100 | $809 | $8 |
| Pantoprazole | 24 | $792 | $33 |
| Albuterol Sulfate Hfa | 11 | $723 | $66 |
| Amlodipine Besylate | 68 | $708 | $10 |
| Trazodone | 56 | $624 | $11 |
| Diclofenac | 19 | $608 | $32 |
| Metformin | 60 | $540 | $9 |
| Losartan | 26 | $429 | $17 |
| Allopurinol | 40 | $383 | $10 |
| Losartan-Hydrochlorothiazide | 30 | $359 | $12 |
| Sertraline | 24 | $347 | $14 |
| Lisinopril | 38 | $333 | $9 |
| Metoprolol | 21 | $327 | $16 |
| Lisinopril-Hydrochlorothiazide | 44 | $318 | $7 |
| Tamsulosin | 24 | $292 | $12 |
| Escitalopram | 18 | $257 | $14 |
| Omeprazole | 16 | $236 | $15 |
| Citalopram Hbr | 12 | $221 | $18 |
| Hydrochlorothiazide | 37 | $205 | $6 |
| Rosuvastatin | 20 | $192 | $10 |
| Simvastatin | 20 | $180 | $9 |
| Glipizide | 16 | $124 | $8 |
| Alendronate | 11 | $86 | $8 |
| Furosemide | 11 | $78 | $7 |
| Metoprolol | 11 | $62 | $6 |
| Clonazepam | 17 | $51 | $3 |
2020: 48 drugs
| Eliquis | 32 | $19,971 | $624 |
| Flovent Hfa | 36 | $17,055 | $474 |
| Xarelto | 14 | $8,691 | $621 |
| Atorvastatin | 344 | $4,296 | $12 |
| Levothyroxine | 140 | $2,903 | $21 |
| Shingrix | 11 | $1,910 | $174 |
| Ezetimibe | 14 | $1,846 | $132 |
| Montelukast | 94 | $1,577 | $17 |
| Bupropion Xl | 41 | $1,303 | $32 |
| Losartan-Hydrochlorothiazide | 30 | $1,252 | $42 |
| Gabapentin | 37 | $920 | $25 |
| Amlodipine Besylate | 94 | $805 | $9 |
| Metoprolol | 36 | $738 | $20 |
| Mirtazapine | 20 | $718 | $36 |
| Metformin | 90 | $667 | $7 |
| Albuterol Sulfate Hfa | 16 | $633 | $40 |
| Metformin Hcl Er | 78 | $628 | $8 |
| Tamsulosin | 37 | $612 | $17 |
| Pantoprazole | 27 | $604 | $22 |
| Sertraline | 42 | $520 | $12 |
| Losartan | 36 | $518 | $14 |
| Trazodone | 54 | $515 | $10 |
| Diltiazem 24hr Er (Cd) | 18 | $492 | $27 |
| Fluticasone Propionate | 16 | $489 | $31 |
| Synthroid | 16 | $467 | $29 |
| Fenofibrate | 16 | $454 | $28 |
| Lisinopril-Hydrochlorothiazide | 45 | $419 | $9 |
| Duloxetine | 18 | $348 | $19 |
| Lisinopril | 74 | $328 | $4 |
| Econazole Nitrate | 11 | $308 | $28 |
| Allopurinol | 31 | $284 | $9 |
| Simvastatin | 31 | $274 | $9 |
| Amiodarone | 13 | $244 | $19 |
| Venlafaxine Hcl Er | 16 | $220 | $14 |
| Hydrochlorothiazide | 23 | $211 | $9 |
| Omeprazole | 18 | $180 | $10 |
| Metoprolol | 38 | $172 | $5 |
| Furosemide | 20 | $142 | $7 |
| Famotidine | 13 | $137 | $11 |
| Citalopram Hbr | 13 | $123 | $9 |
| Zolpidem | 12 | $115 | $10 |
| Prednisone | 20 | $112 | $6 |
| Sumatriptan | 12 | $103 | $9 |
| Hydralazine | 14 | $88 | $6 |
| Clonazepam | 15 | $85 | $6 |
| Risperidone | 12 | $78 | $7 |
| Topiramate | 11 | $63 | $6 |
| Glipizide | 15 | $54 | $4 |
2019: 42 drugs
| Eliquis | 63 | $32,858 | $522 |
| Flovent Hfa | 31 | $12,088 | $390 |
| Humalog Kwikpen U-100 | 13 | $6,916 | $532 |
| Atorvastatin | 192 | $2,860 | $15 |
| Levothyroxine | 135 | $2,464 | $18 |
| Gabapentin | 44 | $1,149 | $26 |
| Tamsulosin | 40 | $1,040 | $26 |
| Proair Hfa | 14 | $961 | $69 |
| Ultra-Fine Short Pen Needle | 11 | $871 | $79 |
| Metoprolol | 36 | $834 | $23 |
| Montelukast | 47 | $827 | $18 |
| Metformin | 97 | $789 | $8 |
| Bupropion Xl | 20 | $768 | $38 |
| Ezetimibe | 11 | $715 | $65 |
| Synthroid | 18 | $694 | $39 |
| Trazodone | 45 | $649 | $14 |
| Ondansetron Odt | 13 | $550 | $42 |
| Sertraline | 45 | $535 | $12 |
| Amlodipine Besylate | 59 | $507 | $9 |
| Alendronate | 16 | $476 | $30 |
| Lisinopril-Hydrochlorothiazide | 58 | $452 | $8 |
| Pantoprazole | 42 | $419 | $10 |
| Diclofenac | 18 | $369 | $21 |
| Metformin Hcl Er | 25 | $337 | $13 |
| Amiodarone | 18 | $301 | $17 |
| Finasteride | 11 | $273 | $25 |
| Lisinopril | 41 | $249 | $6 |
| Losartan | 17 | $235 | $14 |
| Furosemide | 35 | $214 | $6 |
| Isosorbide Mononitrate Er | 21 | $214 | $10 |
| Duloxetine | 11 | $192 | $17 |
| Metoprolol | 42 | $171 | $4 |
| Glipizide | 22 | $158 | $7 |
| Hydrochlorothiazide | 17 | $112 | $7 |
| Azithromycin | 18 | $108 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $101 | $8 |
| Prednisone | 19 | $92 | $5 |
| Hydralazine | 14 | $91 | $6 |
| Topiramate | 12 | $82 | $7 |
| Simvastatin | 12 | $65 | $5 |
| Spironolactone | 17 | $57 | $3 |
| Allopurinol | 15 | $50 | $3 |
2018: 36 drugs
| Eliquis | 31 | $15,901 | $513 |
| Flovent Hfa | 27 | $8,439 | $313 |
| Humalog Kwikpen U-100 | 13 | $6,668 | $513 |
| Januvia | 12 | $5,200 | $433 |
| Duloxetine | 29 | $2,134 | $74 |
| Atorvastatin | 118 | $1,760 | $15 |
| Levothyroxine | 64 | $1,660 | $26 |
| Ezetimibe | 13 | $1,602 | $123 |
| Ventolin Hfa | 16 | $1,003 | $63 |
| Metoprolol | 29 | $872 | $30 |
| Metformin | 75 | $756 | $10 |
| Bupropion Xl | 16 | $741 | $46 |
| Proair Hfa | 12 | $741 | $62 |
| Synthroid | 20 | $606 | $30 |
| Montelukast | 23 | $523 | $23 |
| Diclofenac | 14 | $497 | $36 |
| Sertraline | 27 | $396 | $15 |
| Lisinopril-Hydrochlorothiazide | 58 | $396 | $7 |
| Tamsulosin | 18 | $395 | $22 |
| Oxybutynin Chloride Er | 12 | $307 | $26 |
| Amlodipine Besylate | 28 | $265 | $9 |
| Glipizide | 18 | $261 | $14 |
| Alendronate | 13 | $259 | $20 |
| Omeprazole | 20 | $221 | $11 |
| Pantoprazole | 28 | $204 | $7 |
| Trazodone | 16 | $182 | $11 |
| Lisinopril | 17 | $162 | $10 |
| Losartan | 13 | $159 | $12 |
| Simvastatin | 13 | $153 | $12 |
| Fluticasone Propionate | 11 | $148 | $13 |
| Furosemide | 36 | $112 | $3 |
| Topiramate | 11 | $104 | $9 |
| Prednisone | 19 | $80 | $4 |
| Azithromycin | 12 | $78 | $7 |
| Cyclobenzaprine | 11 | $53 | $5 |
| Hydrochlorothiazide | 12 | $38 | $3 |
2017: 23 drugs
| Humalog Kwikpen U-100 | 13 | $6,651 | $512 |
| Advair Hfa | 11 | $5,216 | $474 |
| Januvia | 12 | $4,628 | $386 |
| Ezetimibe | 12 | $2,970 | $247 |
| Proair Hfa | 26 | $1,469 | $57 |
| Levothyroxine | 36 | $1,045 | $29 |
| Amitriptyline | 16 | $663 | $41 |
| Atorvastatin | 33 | $487 | $15 |
| Bupropion Xl | 12 | $480 | $40 |
| Escitalopram | 22 | $400 | $18 |
| Metformin | 37 | $349 | $9 |
| Omeprazole | 14 | $241 | $17 |
| Nitrofurantoin Mono-Macro | 12 | $230 | $19 |
| Duloxetine | 12 | $224 | $19 |
| Gabapentin | 14 | $188 | $13 |
| Lisinopril-Hydrochlorothiazide | 23 | $180 | $8 |
| Trazodone | 21 | $180 | $9 |
| Simvastatin | 12 | $133 | $11 |
| Triamcinolone Acetonide | 12 | $130 | $11 |
| Sumatriptan | 11 | $127 | $12 |
| Pantoprazole | 12 | $104 | $9 |
| Topiramate | 11 | $104 | $9 |
| Amlodipine Besylate | 12 | $76 | $6 |
2016: 8 drugs
| Econazole Nitrate | 21 | $1,974 | $94 |
| Levothyroxine | 20 | $642 | $32 |
| Proair Hfa | 12 | $641 | $53 |
| Atorvastatin | 19 | $420 | $22 |
| Escitalopram | 19 | $415 | $22 |
| Metformin | 29 | $297 | $10 |
| Bupropion Xl | 15 | $264 | $18 |
| Lorazepam | 12 | $84 | $7 |
2015: 2 drugs
| Metformin | 13 | $189 | $15 |
| Amlodipine Besylate | 24 | $174 | $7 |
2014: 2 drugs
| Lisinopril | 22 | $113 | $5 |
| Amlodipine Besylate | 14 | $79 | $6 |
Money from drug and device companies
$20 in 2025
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $20 | 1 payment
|
See the published payment
| Exact Sciences | Meals · 2025-02-15 | Cologuard Collection Kit | $20 |
Professional record
- NPI
- 1639355944
- Licence
- CA A73520California A73520: Current · expires 2028-09-30
- Trained
- Jefferson Medical College of Thomas Jefferson University, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 15195 National Ave, Suite 205, Los Gatos, CA, 95032
- NPI first listed
- 2008-01-16
- NPI last updated
- 2026-09-03
- NPI record certified
- 2026-09-03
This is when the NPI record was last certified, not a medical board exam.